For example, Deken’s group (47) investigated the in vitro and in vivo antitumor efficacy of photodynamic diagnosis and therapy using BNCs targeting HER2, which were found to bind specifically to the target and showed a higher affinity for HER2-positive tumor cells. The gene discussed is ERBB2; the disease is neoplasm.